바이오정보모아 (BioJungboMoa) — ADC · Antibody

8428프로그램 40FDA 승인

175오늘 방문

5,301누적 방문

7303갱신 대기 S–CData Tier S/A/B차세대 →Insight 1032HER2 breast 4683Antibody 2713CGT →Psoriasis →NSCLC 40FDA 승인

피드 Data Tier 차세대 Insight

l-leucovorin (l-leucovorin)

Metastatic Colorectal Cancer · Gastric Cancer

#GastricCancer#ADC#Phase3#인기#항체약물접합체+3

효능 ORR 36.6%임상시험 60상태 ACTIVE

CGTBiologicstaleTransMolecularPhase 1

Chlorotoxin (EQ, Chlorotoxin, Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT/ICV dual delivery))

Recurrent Glioblastoma; Recurrent Malignant Glioma · CD19

#CD19#CGT#Phase1#인기#세포유전치료+5

임상시험 60상태 RECRUITING

CGTBiologicstaleMedigene AGPhase 2

Lymphodepletion (Lymphodepletion)

Epithelial Ovarian Cancer; Gastro-esophageal Junction Cancer · FRα

#FR#CGT#Phase2#인기#세포유전치료+5

효능 0%임상시험 60상태 DISCONTINUED

ADCBiologicstaleCanadian Cancer Trials Groupderuxtecan (T-DXd) showed a…Phase 2

darolutamide (darolutamide)

Prostate Cancer · Genitourinary Cancers

#GenitourinaryCancers#ADC#Phase2#인기#항체약물접합체+4

임상시험 60상태 RECRUITING

CGTBiologicstaleNational Heart, Lung, and Blood…Phase 2

Haploidentical Hematopoietic Cell Transplantation (Haploidentical Hematopoietic Cell Transplantation)

Hemoglobinopathy (Disorder); Severe Aplastic Anemia · Primary Immune Deficiency Disorders

#PrimaryImmuneDeficiencyDisorders#CGT#Phase2#인기#세포유전치료+5

임상시험 60상태 RECRUITING

CGTBiologicstaleGamma Medica-IdeasPhase 2

tamoxifen citrate (tamoxifen citrate)

Male Breast Cancer; Stage II Breast Cancer · Breast Cancer

#BreastCancer#CGT#Phase2#인기#세포유전치료+5

효능 ORR 13%임상시험 60상태 ACTIVE

AntibodystaleRochegovitecan in patients with …Preclinical

MPDL3280A (Atezolizumab, Atezolizumab (MPDL3280A))

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Preclinical#인기#항체+4

효능 ORR 46.4%임상시험 60상태 ACTIVE

ADCBiologicAscendis Pharma Endocrinology D…Preclinical

Targeted drugs (Targeted drugs)

Immune-related Adverse Event; Malignant Solid Tumors · Immune-related Adverse Event

효능 ORR 15%임상시험 60상태 RECRUITING

AntibodystaleMario Negri Institute for Pharm…Approved

Certolizumab pegol (Certolizumab pegol)

Rheumatoid Arthritis · Crohn's Disease

#CrohnsDisease#Antibody#Approved#인기#항체+4

효능 ORR 5%임상시험 60상태 ACTIVE

CGTBiologicMedigene AGPhase 1

MDG1015 (TCR-T cells, TCR-T cells (MDG1015))

Epithelial Ovarian Cancer; Gastro-esophageal Junction Cancer · Epithelial Ovarian Cancer

#EpithelialOvarianCancer#CGT#Phase1#인기#세포유전치료+5

효능 ORR 11.8%임상시험 60상태 RECRUITING

ADCBiologicstaleMerck Sharp & Dohme LLCPhase 1

Gemcitabine/Cisplatin II (Gemcitabine/Cisplatin II)

Muscle Invasive Bladder Urothelial Carcinoma · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#ADC#Phase1#인기#항체약물접합체+2

효능 ORR 72%임상시험 60상태 ACTIVE

ADCBiologicSeagen Inc.sPhase 1

rifampin (rifampin)

Carcinomas; Disease, Hodgkin · Carcinomas

#Carcinomas#ADC#Phase1#인기#항체약물접합체+5

임상시험 60상태 ACTIVE

CGTBiologicstaleSabz BiomedicalsPhase 2

cytokine-induced killer cell (cytokine-induced killer cell)

Colon Cancer Stage IV · Solid Tumors

#SolidTumors#CGT#Phase2#인기#세포유전치료+5

임상시험 60상태 ACTIVE

CGTBiologicstaleTransMolecularPhase 1

Chlorotoxin (EQ, Chlorotoxin, Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT delivery))

Recurrent Glioblastoma; Recurrent Malignant Glioma · CD19

#CD19#CGT#Phase1#인기#세포유전치료+5

임상시험 60상태 RECRUITING

CGTBiologicstaleEpicentRx, Inc.Phase 2

Checkpoint Inhibitor, Immune (Checkpoint Inhibitor, Immune)

Solid Tumor, Adult; Cancer · Solid Tumor, Adult

#SolidTumorAdult#CGT#Phase2#인기#세포유전치료+5

효능 ORR 59%임상시험 60상태 RECRUITING

CGTBiologicstaleAmerican Gene Technologies Inte…sPreclinical

Gene modified therapy (Gene modified therapy)

HIV · HIV

#HIV#CGT#Preclinical#인기#세포유전치료+4

효능 ORR 41.6%임상시험 60상태 ACTIVE

ADCBiologicMerckVedotin ± Pe…Phase 2

nivolumab OR pembrolizumab (glembatumumab vedotin and PD-1 targeted checkpoint inhibitor, glembatumumab vedotin and PD-1 targeted checkpoint inhibitor (nivolumab OR pembrolizumab))

Melanoma · PD-1

#PD-1#ADC#Phase2#인기#항체약물접합체+5

효능 ORR 50%임상시험 60상태 DISCONTINUED

ADCBiologicAbbVievedotin and mirvetuximab so…Phase 2

Lubricating Eye Drops (Lubricating Eye Drops)

Recurrent Ovarian Cancer; Folate Receptor-Alpha Positive · Recurrent Ovarian Cancer

#RecurrentOvarianCancer#ADC#Phase2#인기#항체약물접합체+5

효능 ORR 0.02%임상시험 60상태 RECRUITING

ADCBiologicMylan Pharmaceuticals IncDM1A-mediated epigenetic si…Phase 1

Verapamil (Verapamil)

Recurrent Hodgkin Lymphoma; Refractory Hodgkin Lymphoma · FRα

#FR#ADC#Phase1#인기#항체약물접합체+5

임상시험 60상태 ACTIVE

ADCBiologicNanogen Pharmaceutical Biotechn…Phase 2

Neulasta (Neulasta)

Hodgkin Lymphoma; Anaplastic Large Cell Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+3

효능 ORR 64%임상시험 59상태 ACTIVE

CGTBiologicstaleImmunityBio, Inc.sPhase 2

Activated NK Cells (M-CENK, M-CENK (Activated NK Cells))

High-risk Prostate Cancer · High-risk Prostate Cancer

#High-riskProstateCancer#CGT#Phase2#인기#세포유전치료+4

임상시험 59상태 DISCONTINUED

AntibodystaleUCB PharmaApproved

Certolizumab (Certolizumab)

Psoriasis; Atopic Dermatitis · Chronic Nonbacterial Osteomyelitis

#ChronicNonbacterialOsteomyelitis#Antibody#Approved#인기#항체+5

효능 ORR 5%임상시험 59상태 RECRUITING

CGTBiologicstaleMerck Sharp & Dohme LLCPhase 2

Interferon-alpha (Interferon-alpha)

Lymphoproliferative Disorder; HHV-8 · Lymphoproliferative Disorder

#LymphoproliferativeDisorder#CGT#Phase2#인기#세포유전치료+5

임상시험 59상태 RECRUITING

AntibodystaleRegeneronDemonstratePhase 2

Cemiplimab + Fianlimab [Fixed Dose Combination (FDC, Cemiplimab + Fianlimab [Fixed Dose Combination, Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)])

Ovarian Cancer; Fallopian Tube Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase2#인기#항체+5

효능 ORR 100%임상시험 59상태 RECRUITING

ADCBiologicstaleKaryopharm Therapeutics IncPhase 2

Clarithromycin (Clarithromycin)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase2#인기#항체약물접합체+2

효능 ORR 6%임상시험 59상태 RECRUITING

12 / 142 페이지

← 이전 다음 →

전체 8,428개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 175 / 5,301

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

빠른 검색 · 이슈 태그

l-leucovorin (l-leucovorin)

Chlorotoxin (EQ, Chlorotoxin, Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT/ICV dual delivery))

Lymphodepletion (Lymphodepletion)

darolutamide (darolutamide)

Haploidentical Hematopoietic Cell Transplantation (Haploidentical Hematopoietic Cell Transplantation)

tamoxifen citrate (tamoxifen citrate)

MPDL3280A (Atezolizumab, Atezolizumab (MPDL3280A))

Targeted drugs (Targeted drugs)

Certolizumab pegol (Certolizumab pegol)

MDG1015 (TCR-T cells, TCR-T cells (MDG1015))

Gemcitabine/Cisplatin II (Gemcitabine/Cisplatin II)

rifampin (rifampin)

cytokine-induced killer cell (cytokine-induced killer cell)

Chlorotoxin (EQ, Chlorotoxin, Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT delivery))

Checkpoint Inhibitor, Immune (Checkpoint Inhibitor, Immune)

Gene modified therapy (Gene modified therapy)

nivolumab OR pembrolizumab (glembatumumab vedotin and PD-1 targeted checkpoint inhibitor, glembatumumab vedotin and PD-1 targeted checkpoint inhibitor (nivolumab OR pembrolizumab))

Lubricating Eye Drops (Lubricating Eye Drops)

Verapamil (Verapamil)

Neulasta (Neulasta)

Activated NK Cells (M-CENK, M-CENK (Activated NK Cells))

Certolizumab (Certolizumab)

Interferon-alpha (Interferon-alpha)

Cemiplimab + Fianlimab [Fixed Dose Combination (FDC, Cemiplimab + Fianlimab [Fixed Dose Combination, Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)])

Clarithromycin (Clarithromycin)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

l-leucovorin (l-leucovorin)

Chlorotoxin (EQ, Chlorotoxin, Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT/ICV dual delivery))

Lymphodepletion (Lymphodepletion)

darolutamide (darolutamide)

Haploidentical Hematopoietic Cell Transplantation (Haploidentical Hematopoietic Cell Transplantation)

tamoxifen citrate (tamoxifen citrate)

MPDL3280A (Atezolizumab, Atezolizumab (MPDL3280A))

Targeted drugs (Targeted drugs)

Certolizumab pegol (Certolizumab pegol)

MDG1015 (TCR-T cells, TCR-T cells (MDG1015))

Gemcitabine/Cisplatin II (Gemcitabine/Cisplatin II)

rifampin (rifampin)

cytokine-induced killer cell (cytokine-induced killer cell)

Chlorotoxin (EQ, Chlorotoxin, Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT delivery))

Checkpoint Inhibitor, Immune (Checkpoint Inhibitor, Immune)

Gene modified therapy (Gene modified therapy)

nivolumab OR pembrolizumab (glembatumumab vedotin and PD-1 targeted checkpoint inhibitor, glembatumumab vedotin and PD-1 targeted checkpoint inhibitor (nivolumab OR pembrolizumab))

Lubricating Eye Drops (Lubricating Eye Drops)

Verapamil (Verapamil)

Neulasta (Neulasta)

Activated NK Cells (M-CENK, M-CENK (Activated NK Cells))

Certolizumab (Certolizumab)

Interferon-alpha (Interferon-alpha)

Cemiplimab + Fianlimab [Fixed Dose Combination (FDC, Cemiplimab + Fianlimab [Fixed Dose Combination, Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)])

Clarithromycin (Clarithromycin)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

l-leucovorin (l-leucovorin)

Chlorotoxin (EQ, Chlorotoxin, Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT/ICV dual delivery))

Lymphodepletion (Lymphodepletion)

darolutamide (darolutamide)

Haploidentical Hematopoietic Cell Transplantation (Haploidentical Hematopoietic Cell Transplantation)

tamoxifen citrate (tamoxifen citrate)

MPDL3280A (Atezolizumab, Atezolizumab (MPDL3280A))

Targeted drugs (Targeted drugs)

Certolizumab pegol (Certolizumab pegol)

MDG1015 (TCR-T cells, TCR-T cells (MDG1015))

Gemcitabine/Cisplatin II (Gemcitabine/Cisplatin II)

rifampin (rifampin)

cytokine-induced killer cell (cytokine-induced killer cell)

Chlorotoxin (EQ, Chlorotoxin, Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT delivery))

Checkpoint Inhibitor, Immune (Checkpoint Inhibitor, Immune)

Gene modified therapy (Gene modified therapy)

nivolumab OR pembrolizumab (glembatumumab vedotin and PD-1 targeted checkpoint inhibitor, glembatumumab vedotin and PD-1 targeted checkpoint inhibitor (nivolumab OR pembrolizumab))

Lubricating Eye Drops (Lubricating Eye Drops)

Verapamil (Verapamil)